CSNK2A1/CK II alpha anticorps (C-Term)
Aperçu rapide pour CSNK2A1/CK II alpha anticorps (C-Term) (ABIN7450124)
Antigène
Voir toutes CSNK2A1/CK II alpha (CSNK2A1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Fonction
- Rabbit anti-CKII alpha' Antibody, Affinity Purified
-
Homologie
- Bovine
-
Purification
- Affinity Purified
-
Immunogène
- between AA 300 and C-term
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- CSNK2A1/CK II alpha (CSNK2A1) (Casein Kinase 2 alpha 1 (CSNK2A1))
-
Autre désignation
- CKII alpha
-
Sujet
- Background: Casein kinase II (CKII) is a serine/threonine protein kinase that is required for progression through the cell cycle but whose major functions are not clearly understood. CKII is composed of a heterotetrameric complex that includes alpha and alpha-prime catalytic subunits and a beta non-catalytic subunit. Although from independent genes, CKII alpha and CKII alpha-prime can compensate for each other for some functions. However in response to ionizing radiation (IR) damage, CKII alpha and CKII alpha-prime appear to function independently in inhibiting apoptosis signaling.
-
ID gène
- 1459
-
NCBI Accession
- NP_001887
-
UniProt
- P19784
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-